The COVID-19 pandemic has created the need for an accelerated drug development paradigm to bring vaccines to the masses. Several public-private partnerships, including Operation Warp Speed (OWS), helped fund an accelerated research & development (R&D) framework in which low-risk vaccines, likely to be successful, were supported via federal spending. Our founder Dr. Gary Michelson makes the case for why increased fast tracking of funding and development for innovative scientific developments is key for our future in the latest COVID-19 edition of National Academy of Inventors’ Technology & Innovation Journal.
The Michelson Institute for Intellectual Property, an initiative of the Michelson 20MM Foundation, provides access to empowering IP education for budding inventors and entrepreneurs. Michelson 20MM was founded thanks to the generous support of renowned spinal surgeon Dr. Gary K. Michelson and Alya Michelson. To learn more, visit 20mm.org.